Idorsia Ltd. (IDRSF)
5.75
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Idorsia SG&A Expense (Quarterly) : 77.58M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | 77.58M |
| September 30, 2025 | 64.98M |
| June 30, 2025 | 61.75M |
| March 31, 2025 | 58.29M |
| December 31, 2024 | 78.64M |
| September 30, 2024 | 60.00M |
| June 30, 2024 | 77.39M |
| March 31, 2024 | 77.54M |
| December 31, 2023 | 89.04M |
| September 30, 2023 | 72.44M |
| June 30, 2023 | 131.27M |
| March 31, 2023 | 126.46M |
| December 31, 2022 | 137.96M |
| September 30, 2022 | 137.57M |
| June 30, 2022 | 130.54M |
| March 31, 2022 | 107.16M |
| December 31, 2021 | 111.73M |
| September 30, 2021 | 54.45M |
| Date | Value |
|---|---|
| June 30, 2021 | 42.84M |
| March 31, 2021 | 32.01M |
| December 31, 2020 | 38.72M |
| September 30, 2020 | 23.92M |
| June 30, 2020 | 18.68M |
| March 31, 2020 | 17.56M |
| December 31, 2019 | 19.41M |
| September 30, 2019 | 15.38M |
| June 30, 2019 | 16.57M |
| March 31, 2019 | 15.50M |
| December 31, 2018 | 16.24M |
| September 30, 2018 | 15.63M |
| June 30, 2018 | 15.58M |
| March 31, 2018 | 14.48M |
| December 31, 2017 | 15.95M |
| September 30, 2017 | 13.37M |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 20.57M |
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| BeOne Medicines Ltd. | 556.75M |
| AC Immune SA | 5.326M |
| CRISPR Therapeutics AG | 17.18M |
| ADC Therapeutics SA | 22.60M |
| MoonLake Immunotherapeutics | 15.51M |